OCCIDENT

OCCIDENT is a venture capital fund investing in Germany and Switzerland, focused on Deep Tech, Biotech and Healthcare. They write Pre-seed, Seed, Series A, Series B and Series C cheques. We hold 6 investments for them on record. 1 person is listed at the firm.

occident.group
Cheque size
Not on record

What OCCIDENT invests in

Deep-tech venture investor backing scientific spin-offs from seed stage, investing its own capital for sustainable societal impact.

People at OCCIDENT

1 named person on record.

  • Officeo•••••@occident.group

Contact addresses at OCCIDENT are partly hidden. Create a free account to see full addresses, a fit score against your own startup, and an outreach email written for this investor.

OCCIDENT portfolio

6 investments on record. Each row says whether the round came from the fund's own portfolio page or from the press, so you can check it.

CompanySectorRoundAmountDate
ImmitraBioDevelops in-vivo gene editing therapiesHealthcareSwitzerland$2.4MJul 2026their site
Tubulis TechnologiesDevelops antibody-drug conjugates for cancerHealthcareGermanyseries-c$308MOct 2025

4 more investments on record for OCCIDENT.

The first two are open to everyone. A free account opens the rest — the company, the round, the amount, the date and where each number came from. No card, no demo call.

Create a free account

Investors similar to OCCIDENT

Or browse the whole directory.

Write to OCCIDENT with something they'll read.

Pitch2Fund scores your startup against OCCIDENT's actual thesis and portfolio, then writes the email — citing the companies they've already backed and why yours fits beside them. Free, and you keep the contacts.